nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Etoposide—brain cancer	0.653	1	CiPCiCtD
Mitoxantrone—CYP1B1—Procarbazine—brain cancer	0.123	0.516	CbGbCtD
Mitoxantrone—TOP2A—Etoposide—brain cancer	0.0323	0.136	CbGbCtD
Mitoxantrone—ABCC1—Etoposide—brain cancer	0.0179	0.0753	CbGbCtD
Mitoxantrone—ABCG2—Carboplatin—brain cancer	0.0143	0.06	CbGbCtD
Mitoxantrone—CYP3A4—Temozolomide—brain cancer	0.0126	0.053	CbGbCtD
Mitoxantrone—ABCG2—Etoposide—brain cancer	0.012	0.0504	CbGbCtD
Mitoxantrone—CYP3A4—Lomustine—brain cancer	0.0107	0.045	CbGbCtD
Mitoxantrone—CYP2E1—Etoposide—brain cancer	0.00854	0.0359	CbGbCtD
Mitoxantrone—ABCB1—Etoposide—brain cancer	0.00432	0.0182	CbGbCtD
Mitoxantrone—CYP3A4—Etoposide—brain cancer	0.00259	0.0109	CbGbCtD
Mitoxantrone—SLC47A1—hindbrain—brain cancer	0.000634	0.0439	CbGeAlD
Mitoxantrone—SLC47A2—head—brain cancer	0.000574	0.0397	CbGeAlD
Mitoxantrone—BTK—pituitary gland—brain cancer	0.000566	0.0392	CbGeAlD
Mitoxantrone—BTK—medulla oblongata—brain cancer	0.000546	0.0378	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—brain cancer	0.000524	0.0363	CbGeAlD
Mitoxantrone—PIM1—pituitary gland—brain cancer	0.00049	0.0339	CbGeAlD
Mitoxantrone—BTK—spinal cord—brain cancer	0.000487	0.0337	CbGeAlD
Mitoxantrone—PIM1—medulla oblongata—brain cancer	0.000473	0.0327	CbGeAlD
Mitoxantrone—TOP2A—Podofilox—Etoposide—brain cancer	0.000444	0.5	CbGdCrCtD
Mitoxantrone—TOP2A—Teniposide—Etoposide—brain cancer	0.000444	0.5	CbGdCrCtD
Mitoxantrone—PIM1—midbrain—brain cancer	0.000433	0.0299	CbGeAlD
Mitoxantrone—PIM1—spinal cord—brain cancer	0.000422	0.0292	CbGeAlD
Mitoxantrone—SLC47A2—brain—brain cancer	0.000416	0.0288	CbGeAlD
Mitoxantrone—PIM1—endocrine gland—brain cancer	0.00038	0.0263	CbGeAlD
Mitoxantrone—PIM1—head—brain cancer	0.000375	0.0259	CbGeAlD
Mitoxantrone—SLC47A1—brainstem—brain cancer	0.000364	0.0252	CbGeAlD
Mitoxantrone—PIM1—central nervous system—brain cancer	0.000342	0.0237	CbGeAlD
Mitoxantrone—PIM1—cerebellum—brain cancer	0.000335	0.0231	CbGeAlD
Mitoxantrone—BTK—brain—brain cancer	0.000314	0.0217	CbGeAlD
Mitoxantrone—PIM1—brain—brain cancer	0.000272	0.0188	CbGeAlD
Mitoxantrone—SLC47A1—gonad—brain cancer	0.000269	0.0186	CbGeAlD
Mitoxantrone—SLC47A1—pituitary gland—brain cancer	0.000263	0.0182	CbGeAlD
Mitoxantrone—SLC47A1—medulla oblongata—brain cancer	0.000254	0.0175	CbGeAlD
Mitoxantrone—CYP1B1—telencephalon—brain cancer	0.000237	0.0164	CbGeAlD
Mitoxantrone—SLC47A1—spinal cord—brain cancer	0.000226	0.0156	CbGeAlD
Mitoxantrone—ABCC1—telencephalon—brain cancer	0.000213	0.0147	CbGeAlD
Mitoxantrone—SLC47A1—endocrine gland—brain cancer	0.000204	0.0141	CbGeAlD
Mitoxantrone—SLC47A1—head—brain cancer	0.000201	0.0139	CbGeAlD
Mitoxantrone—CYP1B1—gonad—brain cancer	0.000197	0.0137	CbGeAlD
Mitoxantrone—CYP1B1—pituitary gland—brain cancer	0.000193	0.0133	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—brain cancer	0.000183	0.0127	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—brain cancer	0.000179	0.0124	CbGeAlD
Mitoxantrone—ABCB1—blood vessel—brain cancer	0.000179	0.0124	CbGeAlD
Mitoxantrone—ABCG2—telencephalon—brain cancer	0.000176	0.0122	CbGeAlD
Mitoxantrone—ABCC1—pituitary gland—brain cancer	0.000173	0.012	CbGeAlD
Mitoxantrone—Alopecia—Procarbazine—brain cancer	0.000167	0.00254	CcSEcCtD
Mitoxantrone—Weight increased—Hydroxyurea—brain cancer	0.000166	0.00253	CcSEcCtD
Mitoxantrone—Drowsiness—Hydroxyurea—brain cancer	0.000163	0.00248	CcSEcCtD
Mitoxantrone—Stomatitis—Hydroxyurea—brain cancer	0.000159	0.00241	CcSEcCtD
Mitoxantrone—Sepsis—Etoposide—brain cancer	0.000158	0.0024	CcSEcCtD
Mitoxantrone—Hypokalaemia—Carmustine—brain cancer	0.000155	0.00237	CcSEcCtD
Mitoxantrone—Dehydration—Temozolomide—brain cancer	0.000154	0.00234	CcSEcCtD
Mitoxantrone—Phlebitis—Etoposide—brain cancer	0.000153	0.00233	CcSEcCtD
Mitoxantrone—CYP2E1—telencephalon—brain cancer	0.000153	0.0105	CbGeAlD
Mitoxantrone—Anaemia—Procarbazine—brain cancer	0.000152	0.00231	CcSEcCtD
Mitoxantrone—Hypokalaemia—Temozolomide—brain cancer	0.00015	0.00229	CcSEcCtD
Mitoxantrone—Swelling—Etoposide—brain cancer	0.00015	0.00228	CcSEcCtD
Mitoxantrone—CYP1B1—endocrine gland—brain cancer	0.000149	0.0103	CbGeAlD
Mitoxantrone—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000149	0.00226	CcSEcCtD
Mitoxantrone—CYP1B1—head—brain cancer	0.000147	0.0102	CbGeAlD
Mitoxantrone—Leukopenia—Procarbazine—brain cancer	0.000147	0.00224	CcSEcCtD
Mitoxantrone—Haemoglobin—Hydroxyurea—brain cancer	0.000147	0.00224	CcSEcCtD
Mitoxantrone—Haemorrhage—Hydroxyurea—brain cancer	0.000146	0.00222	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Etoposide—brain cancer	0.000146	0.00222	CcSEcCtD
Mitoxantrone—SLC47A1—brain—brain cancer	0.000146	0.0101	CbGeAlD
Mitoxantrone—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000146	0.00222	CcSEcCtD
Mitoxantrone—Cough—Procarbazine—brain cancer	0.000143	0.00218	CcSEcCtD
Mitoxantrone—ABCG2—pituitary gland—brain cancer	0.000143	0.00992	CbGeAlD
Mitoxantrone—Convulsion—Procarbazine—brain cancer	0.000142	0.00217	CcSEcCtD
Mitoxantrone—Hypertension—Procarbazine—brain cancer	0.000142	0.00216	CcSEcCtD
Mitoxantrone—Pancytopenia—Carmustine—brain cancer	0.00014	0.00213	CcSEcCtD
Mitoxantrone—BTK—IL-5 Signaling Pathway—IL2—brain cancer	0.00014	0.00503	CbGpPWpGaD
Mitoxantrone—Arthralgia—Procarbazine—brain cancer	0.00014	0.00213	CcSEcCtD
Mitoxantrone—Myalgia—Procarbazine—brain cancer	0.00014	0.00213	CcSEcCtD
Mitoxantrone—PIM1—C-MYB transcription factor network—CCND1—brain cancer	0.00014	0.00502	CbGpPWpGaD
Mitoxantrone—Anxiety—Procarbazine—brain cancer	0.000139	0.00212	CcSEcCtD
Mitoxantrone—Sweating increased—Temozolomide—brain cancer	0.000139	0.00211	CcSEcCtD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000138	0.00497	CbGpPWpGaD
Mitoxantrone—ABCG2—medulla oblongata—brain cancer	0.000138	0.00957	CbGeAlD
Mitoxantrone—Neutropenia—Carmustine—brain cancer	0.000138	0.0021	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—RELA—brain cancer	0.000137	0.00491	CbGpPWpGaD
Mitoxantrone—Anaphylactoid reaction—Etoposide—brain cancer	0.000136	0.00208	CcSEcCtD
Mitoxantrone—Pancytopenia—Temozolomide—brain cancer	0.000135	0.00206	CcSEcCtD
Mitoxantrone—Cardiac failure—Etoposide—brain cancer	0.000135	0.00206	CcSEcCtD
Mitoxantrone—Confusional state—Procarbazine—brain cancer	0.000135	0.00206	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000135	0.00485	CbGpPWpGaD
Mitoxantrone—CYP1B1—central nervous system—brain cancer	0.000134	0.0093	CbGeAlD
Mitoxantrone—Vomiting—Lomustine—brain cancer	0.000134	0.00204	CcSEcCtD
Mitoxantrone—Oedema—Procarbazine—brain cancer	0.000134	0.00204	CcSEcCtD
Mitoxantrone—Neutropenia—Temozolomide—brain cancer	0.000133	0.00203	CcSEcCtD
Mitoxantrone—Infection—Procarbazine—brain cancer	0.000133	0.00203	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Carmustine—brain cancer	0.000133	0.00203	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Temozolomide—brain cancer	0.000133	0.00202	CcSEcCtD
Mitoxantrone—Pneumonia—Carmustine—brain cancer	0.000132	0.00201	CcSEcCtD
Mitoxantrone—Shock—Procarbazine—brain cancer	0.000132	0.00201	CcSEcCtD
Mitoxantrone—CYP1B1—cerebellum—brain cancer	0.000131	0.00909	CbGeAlD
Mitoxantrone—Erectile dysfunction—Temozolomide—brain cancer	0.000131	0.002	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Procarbazine—brain cancer	0.000131	0.002	CcSEcCtD
Mitoxantrone—Chills—Hydroxyurea—brain cancer	0.000131	0.002	CcSEcCtD
Mitoxantrone—Tachycardia—Procarbazine—brain cancer	0.000131	0.00199	CcSEcCtD
Mitoxantrone—Weight increased—Temozolomide—brain cancer	0.00013	0.00198	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Procarbazine—brain cancer	0.00013	0.00197	CcSEcCtD
Mitoxantrone—Renal failure—Carmustine—brain cancer	0.000129	0.00197	CcSEcCtD
Mitoxantrone—Alopecia—Hydroxyurea—brain cancer	0.000129	0.00197	CcSEcCtD
Mitoxantrone—Weight decreased—Temozolomide—brain cancer	0.000129	0.00196	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Temozolomide—brain cancer	0.000129	0.00196	CcSEcCtD
Mitoxantrone—Stomatitis—Carmustine—brain cancer	0.000128	0.00195	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000128	0.0046	CbGpPWpGaD
Mitoxantrone—Urinary tract infection—Carmustine—brain cancer	0.000128	0.00195	CcSEcCtD
Mitoxantrone—Pneumonia—Temozolomide—brain cancer	0.000128	0.00195	CcSEcCtD
Mitoxantrone—Anorexia—Procarbazine—brain cancer	0.000128	0.00195	CcSEcCtD
Mitoxantrone—Erythema—Hydroxyurea—brain cancer	0.000127	0.00194	CcSEcCtD
Mitoxantrone—ABCG2—midbrain—brain cancer	0.000126	0.00875	CbGeAlD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000126	0.00453	CbGpPWpGaD
Mitoxantrone—CYP1B1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000126	0.00453	CbGpPWpGaD
Mitoxantrone—Nausea—Lomustine—brain cancer	0.000126	0.00191	CcSEcCtD
Mitoxantrone—Hypotension—Procarbazine—brain cancer	0.000125	0.00191	CcSEcCtD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000125	0.00449	CbGpPWpGaD
Mitoxantrone—Stomatitis—Temozolomide—brain cancer	0.000124	0.00189	CcSEcCtD
Mitoxantrone—Urinary tract infection—Temozolomide—brain cancer	0.000124	0.00188	CcSEcCtD
Mitoxantrone—ABCG2—spinal cord—brain cancer	0.000123	0.00854	CbGeAlD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000123	0.00443	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000123	0.00442	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000122	0.00186	CcSEcCtD
Mitoxantrone—Paraesthesia—Procarbazine—brain cancer	0.00012	0.00183	CcSEcCtD
Mitoxantrone—CYP2E1—medulla oblongata—brain cancer	0.00012	0.00829	CbGeAlD
Mitoxantrone—Sinusitis—Temozolomide—brain cancer	0.000119	0.00182	CcSEcCtD
Mitoxantrone—Somnolence—Procarbazine—brain cancer	0.000119	0.00182	CcSEcCtD
Mitoxantrone—Haemoglobin—Carmustine—brain cancer	0.000119	0.00181	CcSEcCtD
Mitoxantrone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000118	0.00425	CbGpPWpGaD
Mitoxantrone—ABCC1—cerebellum—brain cancer	0.000118	0.00818	CbGeAlD
Mitoxantrone—Haemorrhage—Carmustine—brain cancer	0.000118	0.0018	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000118	0.0018	CcSEcCtD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000118	0.00423	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—STAT3—brain cancer	0.000118	0.00423	CbGpPWpGaD
Mitoxantrone—Anaemia—Hydroxyurea—brain cancer	0.000118	0.00179	CcSEcCtD
Mitoxantrone—Decreased appetite—Procarbazine—brain cancer	0.000117	0.00177	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Etoposide—brain cancer	0.000117	0.00177	CcSEcCtD
Mitoxantrone—Fatigue—Procarbazine—brain cancer	0.000116	0.00176	CcSEcCtD
Mitoxantrone—Haemoglobin—Temozolomide—brain cancer	0.000115	0.00175	CcSEcCtD
Mitoxantrone—Malaise—Hydroxyurea—brain cancer	0.000115	0.00175	CcSEcCtD
Mitoxantrone—Constipation—Procarbazine—brain cancer	0.000115	0.00175	CcSEcCtD
Mitoxantrone—Pain—Procarbazine—brain cancer	0.000115	0.00175	CcSEcCtD
Mitoxantrone—Hepatitis—Temozolomide—brain cancer	0.000114	0.00174	CcSEcCtD
Mitoxantrone—Haemorrhage—Temozolomide—brain cancer	0.000114	0.00174	CcSEcCtD
Mitoxantrone—Leukopenia—Hydroxyurea—brain cancer	0.000114	0.00173	CcSEcCtD
Mitoxantrone—Pharyngitis—Temozolomide—brain cancer	0.000113	0.00172	CcSEcCtD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000113	0.00405	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—MYC—brain cancer	0.000112	0.00403	CbGpPWpGaD
Mitoxantrone—Sweating increased—Etoposide—brain cancer	0.000111	0.00169	CcSEcCtD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	0.000111	0.00398	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Procarbazine—brain cancer	0.000111	0.00168	CcSEcCtD
Mitoxantrone—Convulsion—Hydroxyurea—brain cancer	0.00011	0.00168	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Procarbazine—brain cancer	0.00011	0.00167	CcSEcCtD
Mitoxantrone—BTK—IL-5 Signaling Pathway—MYC—brain cancer	0.000109	0.00393	CbGpPWpGaD
Mitoxantrone—Pancytopenia—Etoposide—brain cancer	0.000108	0.00165	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	0.000108	0.00387	CbGpPWpGaD
Mitoxantrone—Discomfort—Hydroxyurea—brain cancer	0.000107	0.00163	CcSEcCtD
Mitoxantrone—CYP2E1—spinal cord—brain cancer	0.000107	0.00739	CbGeAlD
Mitoxantrone—Neutropenia—Etoposide—brain cancer	0.000107	0.00162	CcSEcCtD
Mitoxantrone—CYP1B1—brain—brain cancer	0.000107	0.00738	CbGeAlD
Mitoxantrone—Urticaria—Procarbazine—brain cancer	0.000107	0.00162	CcSEcCtD
Mitoxantrone—Abdominal pain—Procarbazine—brain cancer	0.000106	0.00161	CcSEcCtD
Mitoxantrone—Body temperature increased—Procarbazine—brain cancer	0.000106	0.00161	CcSEcCtD
Mitoxantrone—Arrhythmia—Carmustine—brain cancer	0.000106	0.00161	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000105	0.00377	CbGpPWpGaD
Mitoxantrone—Alopecia—Carmustine—brain cancer	0.000104	0.00159	CcSEcCtD
Mitoxantrone—Oedema—Hydroxyurea—brain cancer	0.000104	0.00158	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—STAT3—brain cancer	0.000104	0.00372	CbGpPWpGaD
Mitoxantrone—Infection—Hydroxyurea—brain cancer	0.000103	0.00157	CcSEcCtD
Mitoxantrone—BTK—BCR signaling pathway—RELA—brain cancer	0.000103	0.0037	CbGpPWpGaD
Mitoxantrone—Erythema—Carmustine—brain cancer	0.000103	0.00157	CcSEcCtD
Mitoxantrone—Chills—Temozolomide—brain cancer	0.000102	0.00156	CcSEcCtD
Mitoxantrone—Pneumonia—Etoposide—brain cancer	0.000102	0.00156	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000102	0.00155	CcSEcCtD
Mitoxantrone—CYP1B1—Biological oxidations—CYP2C9—brain cancer	0.000102	0.00365	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—VAV1—brain cancer	0.000101	0.00364	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000101	0.00363	CbGpPWpGaD
Mitoxantrone—Alopecia—Temozolomide—brain cancer	0.000101	0.00154	CcSEcCtD
Mitoxantrone—Skin disorder—Hydroxyurea—brain cancer	0.000101	0.00153	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Etoposide—brain cancer	0.0001	0.00153	CcSEcCtD
Mitoxantrone—CYP1B1—Metapathway biotransformation—CYP2C9—brain cancer	0.0001	0.0036	CbGpPWpGaD
Mitoxantrone—Renal failure—Etoposide—brain cancer	0.0001	0.00152	CcSEcCtD
Mitoxantrone—Myocardial infarction—Etoposide—brain cancer	9.98e-05	0.00152	CcSEcCtD
Mitoxantrone—Back pain—Carmustine—brain cancer	9.95e-05	0.00151	CcSEcCtD
Mitoxantrone—Erythema—Temozolomide—brain cancer	9.94e-05	0.00151	CcSEcCtD
Mitoxantrone—Jaundice—Etoposide—brain cancer	9.92e-05	0.00151	CcSEcCtD
Mitoxantrone—Stomatitis—Etoposide—brain cancer	9.92e-05	0.00151	CcSEcCtD
Mitoxantrone—Anorexia—Hydroxyurea—brain cancer	9.9e-05	0.00151	CcSEcCtD
Mitoxantrone—Hypersensitivity—Procarbazine—brain cancer	9.89e-05	0.0015	CcSEcCtD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—PIK3CG—brain cancer	9.79e-05	0.00352	CbGpPWpGaD
Mitoxantrone—ABCG2—cerebellum—brain cancer	9.79e-05	0.00677	CbGeAlD
Mitoxantrone—Dysgeusia—Temozolomide—brain cancer	9.74e-05	0.00148	CcSEcCtD
Mitoxantrone—ABCC1—S1P1 pathway—VEGFA—brain cancer	9.71e-05	0.00349	CbGpPWpGaD
Mitoxantrone—Vision blurred—Carmustine—brain cancer	9.69e-05	0.00148	CcSEcCtD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	9.68e-05	0.00348	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	9.64e-05	0.00346	CbGpPWpGaD
Mitoxantrone—Asthenia—Procarbazine—brain cancer	9.63e-05	0.00146	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—MYC—brain cancer	9.62e-05	0.00346	CbGpPWpGaD
Mitoxantrone—CYP2E1—endocrine gland—brain cancer	9.62e-05	0.00665	CbGeAlD
Mitoxantrone—Back pain—Temozolomide—brain cancer	9.62e-05	0.00146	CcSEcCtD
Mitoxantrone—ABCC1—brain—brain cancer	9.6e-05	0.00664	CbGeAlD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—VAV1—brain cancer	9.53e-05	0.00342	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—VAV1—brain cancer	9.53e-05	0.00342	CbGpPWpGaD
Mitoxantrone—Anaemia—Carmustine—brain cancer	9.51e-05	0.00145	CcSEcCtD
Mitoxantrone—Agranulocytosis—Etoposide—brain cancer	9.5e-05	0.00145	CcSEcCtD
Mitoxantrone—CYP2E1—head—brain cancer	9.5e-05	0.00657	CbGeAlD
Mitoxantrone—Vision blurred—Temozolomide—brain cancer	9.37e-05	0.00143	CcSEcCtD
Mitoxantrone—PIM1—Ectoderm Differentiation—CTNNB1—brain cancer	9.31e-05	0.00334	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Hydroxyurea—brain cancer	9.26e-05	0.00141	CcSEcCtD
Mitoxantrone—Somnolence—Hydroxyurea—brain cancer	9.23e-05	0.0014	CcSEcCtD
Mitoxantrone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	9.23e-05	0.00332	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Temozolomide—brain cancer	9.22e-05	0.0014	CcSEcCtD
Mitoxantrone—Leukopenia—Carmustine—brain cancer	9.21e-05	0.0014	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—SPP1—brain cancer	9.2e-05	0.0033	CbGpPWpGaD
Mitoxantrone—Anaemia—Temozolomide—brain cancer	9.19e-05	0.0014	CcSEcCtD
Mitoxantrone—Diarrhoea—Procarbazine—brain cancer	9.18e-05	0.0014	CcSEcCtD
Mitoxantrone—Dyspepsia—Hydroxyurea—brain cancer	9.14e-05	0.00139	CcSEcCtD
Mitoxantrone—Decreased appetite—Hydroxyurea—brain cancer	9.03e-05	0.00137	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	9e-05	0.00323	CbGpPWpGaD
Mitoxantrone—Malaise—Temozolomide—brain cancer	8.96e-05	0.00136	CcSEcCtD
Mitoxantrone—Fatigue—Hydroxyurea—brain cancer	8.95e-05	0.00136	CcSEcCtD
Mitoxantrone—Convulsion—Carmustine—brain cancer	8.91e-05	0.00136	CcSEcCtD
Mitoxantrone—Leukopenia—Temozolomide—brain cancer	8.9e-05	0.00135	CcSEcCtD
Mitoxantrone—Hypertension—Carmustine—brain cancer	8.88e-05	0.00135	CcSEcCtD
Mitoxantrone—Constipation—Hydroxyurea—brain cancer	8.88e-05	0.00135	CcSEcCtD
Mitoxantrone—Pain—Hydroxyurea—brain cancer	8.88e-05	0.00135	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—VAV1—brain cancer	8.82e-05	0.00317	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—TRPC6—brain cancer	8.82e-05	0.00317	CbGpPWpGaD
Mitoxantrone—Chest pain—Carmustine—brain cancer	8.76e-05	0.00133	CcSEcCtD
Mitoxantrone—Myalgia—Carmustine—brain cancer	8.76e-05	0.00133	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	8.73e-05	0.00313	CbGpPWpGaD
Mitoxantrone—Anxiety—Carmustine—brain cancer	8.73e-05	0.00133	CcSEcCtD
Mitoxantrone—ABCB1—telencephalon—brain cancer	8.69e-05	0.00601	CbGeAlD
Mitoxantrone—Cough—Temozolomide—brain cancer	8.67e-05	0.00132	CcSEcCtD
Mitoxantrone—CYP2E1—central nervous system—brain cancer	8.67e-05	0.006	CbGeAlD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	8.64e-05	0.0031	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—STAT3—brain cancer	8.63e-05	0.0031	CbGpPWpGaD
Mitoxantrone—Convulsion—Temozolomide—brain cancer	8.61e-05	0.00131	CcSEcCtD
Mitoxantrone—Hypertension—Temozolomide—brain cancer	8.58e-05	0.00131	CcSEcCtD
Mitoxantrone—Feeling abnormal—Hydroxyurea—brain cancer	8.56e-05	0.0013	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	8.54e-05	0.00307	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	8.54e-05	0.00307	CbGpPWpGaD
Mitoxantrone—Vomiting—Procarbazine—brain cancer	8.53e-05	0.0013	CcSEcCtD
Mitoxantrone—CYP2E1—cerebellum—brain cancer	8.47e-05	0.00586	CbGeAlD
Mitoxantrone—Confusional state—Carmustine—brain cancer	8.47e-05	0.00129	CcSEcCtD
Mitoxantrone—Arthralgia—Temozolomide—brain cancer	8.46e-05	0.00129	CcSEcCtD
Mitoxantrone—Myalgia—Temozolomide—brain cancer	8.46e-05	0.00129	CcSEcCtD
Mitoxantrone—Rash—Procarbazine—brain cancer	8.46e-05	0.00129	CcSEcCtD
Mitoxantrone—Dermatitis—Procarbazine—brain cancer	8.45e-05	0.00129	CcSEcCtD
Mitoxantrone—Anxiety—Temozolomide—brain cancer	8.43e-05	0.00128	CcSEcCtD
Mitoxantrone—Headache—Procarbazine—brain cancer	8.41e-05	0.00128	CcSEcCtD
Mitoxantrone—Oedema—Carmustine—brain cancer	8.4e-05	0.00128	CcSEcCtD
Mitoxantrone—Discomfort—Temozolomide—brain cancer	8.36e-05	0.00127	CcSEcCtD
Mitoxantrone—Infection—Carmustine—brain cancer	8.34e-05	0.00127	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—PDGFRA—brain cancer	8.3e-05	0.00298	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Carmustine—brain cancer	8.22e-05	0.00125	CcSEcCtD
Mitoxantrone—Body temperature increased—Hydroxyurea—brain cancer	8.21e-05	0.00125	CcSEcCtD
Mitoxantrone—Chills—Etoposide—brain cancer	8.2e-05	0.00125	CcSEcCtD
Mitoxantrone—Tachycardia—Carmustine—brain cancer	8.19e-05	0.00125	CcSEcCtD
Mitoxantrone—Confusional state—Temozolomide—brain cancer	8.18e-05	0.00124	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	8.16e-05	0.00293	CbGpPWpGaD
Mitoxantrone—Anaphylactic shock—Temozolomide—brain cancer	8.11e-05	0.00123	CcSEcCtD
Mitoxantrone—Oedema—Temozolomide—brain cancer	8.11e-05	0.00123	CcSEcCtD
Mitoxantrone—Alopecia—Etoposide—brain cancer	8.07e-05	0.00123	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	8.07e-05	0.0029	CbGpPWpGaD
Mitoxantrone—Infection—Temozolomide—brain cancer	8.06e-05	0.00123	CcSEcCtD
Mitoxantrone—Anorexia—Carmustine—brain cancer	8e-05	0.00122	CcSEcCtD
Mitoxantrone—Nausea—Procarbazine—brain cancer	7.97e-05	0.00121	CcSEcCtD
Mitoxantrone—ABCG2—brain—brain cancer	7.95e-05	0.0055	CbGeAlD
Mitoxantrone—Thrombocytopenia—Temozolomide—brain cancer	7.94e-05	0.00121	CcSEcCtD
Mitoxantrone—Skin disorder—Temozolomide—brain cancer	7.88e-05	0.0012	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—RELA—brain cancer	7.85e-05	0.00282	CbGpPWpGaD
Mitoxantrone—Hypotension—Carmustine—brain cancer	7.85e-05	0.00119	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Temozolomide—brain cancer	7.84e-05	0.00119	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—PDGFRA—brain cancer	7.81e-05	0.0028	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—PDGFRA—brain cancer	7.81e-05	0.0028	CbGpPWpGaD
Mitoxantrone—Dysgeusia—Etoposide—brain cancer	7.79e-05	0.00119	CcSEcCtD
Mitoxantrone—CYP3A4—endocrine gland—brain cancer	7.74e-05	0.00535	CbGeAlD
Mitoxantrone—Anorexia—Temozolomide—brain cancer	7.73e-05	0.00118	CcSEcCtD
Mitoxantrone—Back pain—Etoposide—brain cancer	7.69e-05	0.00117	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	7.65e-05	0.00275	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—RELA—brain cancer	7.65e-05	0.00275	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Hydroxyurea—brain cancer	7.65e-05	0.00116	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Carmustine—brain cancer	7.65e-05	0.00116	CcSEcCtD
Mitoxantrone—PIM1—Ectoderm Differentiation—MYC—brain cancer	7.54e-05	0.00271	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Carmustine—brain cancer	7.54e-05	0.00115	CcSEcCtD
Mitoxantrone—Dyspnoea—Carmustine—brain cancer	7.48e-05	0.00114	CcSEcCtD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	7.48e-05	0.00269	CbGpPWpGaD
Mitoxantrone—Somnolence—Carmustine—brain cancer	7.46e-05	0.00114	CcSEcCtD
Mitoxantrone—Asthenia—Hydroxyurea—brain cancer	7.45e-05	0.00113	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Temozolomide—brain cancer	7.39e-05	0.00112	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Etoposide—brain cancer	7.38e-05	0.00112	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	7.38e-05	0.00265	CbGpPWpGaD
Mitoxantrone—Anaemia—Etoposide—brain cancer	7.35e-05	0.00112	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—PIK3CG—brain cancer	7.34e-05	0.00264	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Carmustine—brain cancer	7.3e-05	0.00111	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—PPP1R12A—brain cancer	7.3e-05	0.00262	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IRS2—brain cancer	7.29e-05	0.00262	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Temozolomide—brain cancer	7.29e-05	0.00111	CcSEcCtD
Mitoxantrone—ABCB1—gonad—brain cancer	7.25e-05	0.00501	CbGeAlD
Mitoxantrone—Dyspnoea—Temozolomide—brain cancer	7.23e-05	0.0011	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—PDGFRA—brain cancer	7.22e-05	0.00259	CbGpPWpGaD
Mitoxantrone—Somnolence—Temozolomide—brain cancer	7.21e-05	0.0011	CcSEcCtD
Mitoxantrone—Constipation—Carmustine—brain cancer	7.18e-05	0.00109	CcSEcCtD
Mitoxantrone—Pain—Carmustine—brain cancer	7.18e-05	0.00109	CcSEcCtD
Mitoxantrone—Malaise—Etoposide—brain cancer	7.17e-05	0.00109	CcSEcCtD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	7.17e-05	0.00257	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.16e-05	0.00257	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Temozolomide—brain cancer	7.14e-05	0.00109	CcSEcCtD
Mitoxantrone—Leukopenia—Etoposide—brain cancer	7.12e-05	0.00108	CcSEcCtD
Mitoxantrone—Diarrhoea—Hydroxyurea—brain cancer	7.11e-05	0.00108	CcSEcCtD
Mitoxantrone—ABCB1—pituitary gland—brain cancer	7.07e-05	0.00489	CbGeAlD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.06e-05	0.00254	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Temozolomide—brain cancer	7.05e-05	0.00107	CcSEcCtD
Mitoxantrone—Fatigue—Temozolomide—brain cancer	6.99e-05	0.00106	CcSEcCtD
Mitoxantrone—CYP3A4—central nervous system—brain cancer	6.97e-05	0.00482	CbGeAlD
Mitoxantrone—Cough—Etoposide—brain cancer	6.94e-05	0.00106	CcSEcCtD
Mitoxantrone—Pain—Temozolomide—brain cancer	6.94e-05	0.00106	CcSEcCtD
Mitoxantrone—Constipation—Temozolomide—brain cancer	6.94e-05	0.00106	CcSEcCtD
Mitoxantrone—Feeling abnormal—Carmustine—brain cancer	6.92e-05	0.00105	CcSEcCtD
Mitoxantrone—Convulsion—Etoposide—brain cancer	6.89e-05	0.00105	CcSEcCtD
Mitoxantrone—CYP2E1—brain—brain cancer	6.88e-05	0.00476	CbGeAlD
Mitoxantrone—Hypertension—Etoposide—brain cancer	6.87e-05	0.00104	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Carmustine—brain cancer	6.87e-05	0.00104	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—IRS2—brain cancer	6.85e-05	0.00246	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IRS2—brain cancer	6.85e-05	0.00246	CbGpPWpGaD
Mitoxantrone—ABCB1—medulla oblongata—brain cancer	6.82e-05	0.00472	CbGeAlD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	6.78e-05	0.00244	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—RELA—brain cancer	6.77e-05	0.00243	CbGpPWpGaD
Mitoxantrone—Chest pain—Etoposide—brain cancer	6.77e-05	0.00103	CcSEcCtD
Mitoxantrone—Discomfort—Etoposide—brain cancer	6.69e-05	0.00102	CcSEcCtD
Mitoxantrone—Feeling abnormal—Temozolomide—brain cancer	6.69e-05	0.00102	CcSEcCtD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	6.67e-05	0.0024	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP2C9—brain cancer	6.64e-05	0.00239	CbGpPWpGaD
Mitoxantrone—Body temperature increased—Carmustine—brain cancer	6.64e-05	0.00101	CcSEcCtD
Mitoxantrone—Abdominal pain—Carmustine—brain cancer	6.64e-05	0.00101	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Temozolomide—brain cancer	6.63e-05	0.00101	CcSEcCtD
Mitoxantrone—Vomiting—Hydroxyurea—brain cancer	6.6e-05	0.001	CcSEcCtD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	6.55e-05	0.00235	CbGpPWpGaD
Mitoxantrone—Rash—Hydroxyurea—brain cancer	6.55e-05	0.000996	CcSEcCtD
Mitoxantrone—Confusional state—Etoposide—brain cancer	6.55e-05	0.000996	CcSEcCtD
Mitoxantrone—Dermatitis—Hydroxyurea—brain cancer	6.54e-05	0.000995	CcSEcCtD
Mitoxantrone—Headache—Hydroxyurea—brain cancer	6.51e-05	0.00099	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Etoposide—brain cancer	6.49e-05	0.000988	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.46e-05	0.00232	CbGpPWpGaD
Mitoxantrone—Infection—Etoposide—brain cancer	6.45e-05	0.000981	CcSEcCtD
Mitoxantrone—Urticaria—Temozolomide—brain cancer	6.45e-05	0.000981	CcSEcCtD
Mitoxantrone—Abdominal pain—Temozolomide—brain cancer	6.41e-05	0.000976	CcSEcCtD
Mitoxantrone—Body temperature increased—Temozolomide—brain cancer	6.41e-05	0.000976	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	6.37e-05	0.00229	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Etoposide—brain cancer	6.36e-05	0.000967	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—IRS2—brain cancer	6.34e-05	0.00228	CbGpPWpGaD
Mitoxantrone—Tachycardia—Etoposide—brain cancer	6.34e-05	0.000964	CcSEcCtD
Mitoxantrone—Skin disorder—Etoposide—brain cancer	6.31e-05	0.000959	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Etoposide—brain cancer	6.28e-05	0.000955	CcSEcCtD
Mitoxantrone—ABCB1—midbrain—brain cancer	6.24e-05	0.00431	CbGeAlD
Mitoxantrone—Anorexia—Etoposide—brain cancer	6.19e-05	0.000942	CcSEcCtD
Mitoxantrone—Hypersensitivity—Carmustine—brain cancer	6.19e-05	0.000941	CcSEcCtD
Mitoxantrone—Nausea—Hydroxyurea—brain cancer	6.17e-05	0.000939	CcSEcCtD
Mitoxantrone—ABCB1—spinal cord—brain cancer	6.09e-05	0.00421	CbGeAlD
Mitoxantrone—CYP3A4—Irinotecan Pathway—APC—brain cancer	6.08e-05	0.00218	CbGpPWpGaD
Mitoxantrone—Hypotension—Etoposide—brain cancer	6.07e-05	0.000923	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.05e-05	0.00217	CbGpPWpGaD
Mitoxantrone—Asthenia—Carmustine—brain cancer	6.02e-05	0.000916	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	6.01e-05	0.00216	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Temozolomide—brain cancer	5.98e-05	0.000909	CcSEcCtD
Mitoxantrone—Paraesthesia—Etoposide—brain cancer	5.83e-05	0.000887	CcSEcCtD
Mitoxantrone—Asthenia—Temozolomide—brain cancer	5.82e-05	0.000886	CcSEcCtD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.8e-05	0.00208	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Etoposide—brain cancer	5.79e-05	0.000881	CcSEcCtD
Mitoxantrone—Somnolence—Etoposide—brain cancer	5.77e-05	0.000878	CcSEcCtD
Mitoxantrone—Diarrhoea—Carmustine—brain cancer	5.74e-05	0.000874	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	5.74e-05	0.00206	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.68e-05	0.00204	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—RELA—brain cancer	5.67e-05	0.00204	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Etoposide—brain cancer	5.64e-05	0.000859	CcSEcCtD
Mitoxantrone—Fatigue—Etoposide—brain cancer	5.6e-05	0.000852	CcSEcCtD
Mitoxantrone—Constipation—Etoposide—brain cancer	5.55e-05	0.000845	CcSEcCtD
Mitoxantrone—Pain—Etoposide—brain cancer	5.55e-05	0.000845	CcSEcCtD
Mitoxantrone—Diarrhoea—Temozolomide—brain cancer	5.55e-05	0.000845	CcSEcCtD
Mitoxantrone—ABCB1—endocrine gland—brain cancer	5.48e-05	0.00379	CbGeAlD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.45e-05	0.00196	CbGpPWpGaD
Mitoxantrone—ABCB1—head—brain cancer	5.41e-05	0.00374	CbGeAlD
Mitoxantrone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	5.39e-05	0.00194	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—MYC—brain cancer	5.39e-05	0.00194	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	5.37e-05	0.00193	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Etoposide—brain cancer	5.35e-05	0.000814	CcSEcCtD
Mitoxantrone—Vomiting—Carmustine—brain cancer	5.34e-05	0.000812	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Etoposide—brain cancer	5.31e-05	0.000808	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.3e-05	0.00191	CbGpPWpGaD
Mitoxantrone—Rash—Carmustine—brain cancer	5.29e-05	0.000805	CcSEcCtD
Mitoxantrone—Dermatitis—Carmustine—brain cancer	5.29e-05	0.000805	CcSEcCtD
Mitoxantrone—Headache—Carmustine—brain cancer	5.26e-05	0.0008	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.2e-05	0.00187	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	5.19e-05	0.00187	CbGpPWpGaD
Mitoxantrone—Vomiting—Temozolomide—brain cancer	5.16e-05	0.000785	CcSEcCtD
Mitoxantrone—Urticaria—Etoposide—brain cancer	5.16e-05	0.000785	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.14e-05	0.00185	CbGpPWpGaD
Mitoxantrone—Abdominal pain—Etoposide—brain cancer	5.13e-05	0.000781	CcSEcCtD
Mitoxantrone—Body temperature increased—Etoposide—brain cancer	5.13e-05	0.000781	CcSEcCtD
Mitoxantrone—Rash—Temozolomide—brain cancer	5.12e-05	0.000778	CcSEcCtD
Mitoxantrone—Dermatitis—Temozolomide—brain cancer	5.11e-05	0.000778	CcSEcCtD
Mitoxantrone—Headache—Temozolomide—brain cancer	5.08e-05	0.000773	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—ERBB2—brain cancer	5e-05	0.00179	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	4.99e-05	0.00179	CbGpPWpGaD
Mitoxantrone—Nausea—Carmustine—brain cancer	4.99e-05	0.000759	CcSEcCtD
Mitoxantrone—ABCB1—central nervous system—brain cancer	4.94e-05	0.00341	CbGeAlD
Mitoxantrone—ABCB1—cerebellum—brain cancer	4.83e-05	0.00334	CbGeAlD
Mitoxantrone—Nausea—Temozolomide—brain cancer	4.82e-05	0.000733	CcSEcCtD
Mitoxantrone—Hypersensitivity—Etoposide—brain cancer	4.78e-05	0.000728	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.78e-05	0.00172	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	4.77e-05	0.00171	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	4.73e-05	0.0017	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—ERBB2—brain cancer	4.7e-05	0.00169	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	4.7e-05	0.00169	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	4.67e-05	0.00168	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—SKP2—brain cancer	4.67e-05	0.00168	CbGpPWpGaD
Mitoxantrone—Asthenia—Etoposide—brain cancer	4.66e-05	0.000709	CcSEcCtD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	4.63e-05	0.00166	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.63e-05	0.00166	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.55e-05	0.00163	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Etoposide—brain cancer	4.44e-05	0.000676	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—RELA—brain cancer	4.38e-05	0.00157	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—ERBB2—brain cancer	4.35e-05	0.00156	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.26e-05	0.00153	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.17e-05	0.0015	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.17e-05	0.0015	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	4.15e-05	0.00149	CbGpPWpGaD
Mitoxantrone—Vomiting—Etoposide—brain cancer	4.13e-05	0.000628	CcSEcCtD
Mitoxantrone—Rash—Etoposide—brain cancer	4.09e-05	0.000623	CcSEcCtD
Mitoxantrone—Dermatitis—Etoposide—brain cancer	4.09e-05	0.000622	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	4.08e-05	0.00146	CbGpPWpGaD
Mitoxantrone—Headache—Etoposide—brain cancer	4.07e-05	0.000619	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.04e-05	0.00145	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	3.97e-05	0.00143	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.93e-05	0.00141	CbGpPWpGaD
Mitoxantrone—ABCB1—brain—brain cancer	3.92e-05	0.00271	CbGeAlD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.9e-05	0.0014	CbGpPWpGaD
Mitoxantrone—Nausea—Etoposide—brain cancer	3.86e-05	0.000587	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	3.82e-05	0.00137	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—CDK4—brain cancer	3.78e-05	0.00136	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	3.7e-05	0.00133	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—VAV1—brain cancer	3.7e-05	0.00133	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.7e-05	0.00133	CbGpPWpGaD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.69e-05	0.00132	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—VAV1—brain cancer	3.56e-05	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—EGFR—brain cancer	3.46e-05	0.00124	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	3.35e-05	0.0012	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—SKP2—brain cancer	3.31e-05	0.00119	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	3.3e-05	0.00119	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—EGFR—brain cancer	3.26e-05	0.00117	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	3.26e-05	0.00117	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	3.19e-05	0.00114	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DTX2—brain cancer	3.18e-05	0.00114	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.16e-05	0.00113	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	3.14e-05	0.00113	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.08e-05	0.00111	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.04e-05	0.00109	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PDGFRA—brain cancer	3.03e-05	0.00109	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—EGFR—brain cancer	3.02e-05	0.00108	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDK6—brain cancer	2.95e-05	0.00106	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.95e-05	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PDGFRA—brain cancer	2.91e-05	0.00105	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.88e-05	0.00103	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.85e-05	0.00103	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SKP2—brain cancer	2.83e-05	0.00102	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	2.69e-05	0.000966	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IRS2—brain cancer	2.66e-05	0.000956	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	2.66e-05	0.000955	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—IRS2—brain cancer	2.56e-05	0.000918	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.54e-05	0.000912	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.52e-05	0.000905	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.52e-05	0.000904	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	2.49e-05	0.000893	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HES5—brain cancer	2.33e-05	0.000838	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—BRCA2—brain cancer	2.3e-05	0.000825	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCNE1—brain cancer	2.22e-05	0.000799	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.21e-05	0.000795	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.2e-05	0.000792	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	2.2e-05	0.000791	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—VAV1—brain cancer	2.16e-05	0.000775	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.14e-05	0.000768	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.13e-05	0.000764	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.04e-05	0.000732	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.99e-05	0.000716	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.99e-05	0.000716	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—PCNA—brain cancer	1.97e-05	0.000708	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	1.9e-05	0.000684	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.88e-05	0.000676	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—RELA—brain cancer	1.84e-05	0.00066	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB2—brain cancer	1.83e-05	0.000656	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000646	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PDGFRA—brain cancer	1.77e-05	0.000635	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—RELA—brain cancer	1.76e-05	0.000634	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB2—brain cancer	1.75e-05	0.00063	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.75e-05	0.000627	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2—brain cancer	1.74e-05	0.000625	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2C9—brain cancer	1.74e-05	0.000625	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.71e-05	0.000615	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.71e-05	0.000613	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDK4—brain cancer	1.7e-05	0.000612	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.69e-05	0.000608	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.67e-05	0.000601	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—brain cancer	1.61e-05	0.000577	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CTNNB1—brain cancer	1.6e-05	0.000574	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2C9—brain cancer	1.58e-05	0.000568	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.57e-05	0.000565	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IDH1—brain cancer	1.57e-05	0.000564	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRS2—brain cancer	1.55e-05	0.000557	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—BSG—brain cancer	1.53e-05	0.000549	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.5e-05	0.000538	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HEY1—brain cancer	1.49e-05	0.000534	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BSG—brain cancer	1.48e-05	0.000531	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.48e-05	0.000531	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DLL1—brain cancer	1.46e-05	0.000524	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.46e-05	0.000523	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BSG—brain cancer	1.35e-05	0.000483	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—IDH1—brain cancer	1.31e-05	0.000472	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—brain cancer	1.3e-05	0.000468	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.3e-05	0.000465	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—IDH1—brain cancer	1.27e-05	0.000457	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—brain cancer	1.27e-05	0.000455	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SHH—brain cancer	1.24e-05	0.000446	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ENO2—brain cancer	1.24e-05	0.000446	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	1.23e-05	0.000442	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.22e-05	0.000438	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—brain cancer	1.22e-05	0.000437	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—IDH1—brain cancer	1.16e-05	0.000415	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2C9—brain cancer	1.14e-05	0.000408	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—brain cancer	1.1e-05	0.000395	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RELA—brain cancer	1.07e-05	0.000384	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.07e-05	0.000384	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—brain cancer	1.06e-05	0.000382	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ENO2—brain cancer	1.04e-05	0.000373	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.04e-05	0.000372	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.02e-05	0.000366	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ENO2—brain cancer	1.01e-05	0.000361	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	9.87e-06	0.000354	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BSG—brain cancer	9.66e-06	0.000347	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—brain cancer	9.64e-06	0.000346	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.47e-06	0.00034	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—brain cancer	9.31e-06	0.000334	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ENO2—brain cancer	9.14e-06	0.000328	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—VAV1—brain cancer	8.96e-06	0.000322	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—brain cancer	8.82e-06	0.000317	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2C9—brain cancer	8.55e-06	0.000307	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.37e-06	0.0003	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—IDH1—brain cancer	8.3e-06	0.000298	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.28e-06	0.000298	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—brain cancer	8.11e-06	0.000291	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HES1—brain cancer	7.71e-06	0.000277	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—brain cancer	7.37e-06	0.000265	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFRA—brain cancer	7.34e-06	0.000264	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.29e-06	0.000262	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BSG—brain cancer	7.27e-06	0.000261	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—brain cancer	7.24e-06	0.00026	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.71e-06	0.000241	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO2—brain cancer	6.56e-06	0.000236	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.56e-06	0.000236	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS2—brain cancer	6.44e-06	0.000231	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—IDH1—brain cancer	6.25e-06	0.000225	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—brain cancer	5.69e-06	0.000204	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.51e-06	0.000198	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2C9—brain cancer	5.27e-06	0.000189	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO2—brain cancer	4.94e-06	0.000178	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—brain cancer	4.77e-06	0.000171	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—brain cancer	4.61e-06	0.000166	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BSG—brain cancer	4.48e-06	0.000161	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—brain cancer	4.42e-06	0.000159	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—brain cancer	4.19e-06	0.000151	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—brain cancer	3.87e-06	0.000139	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—IDH1—brain cancer	3.85e-06	0.000138	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—brain cancer	3.37e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—brain cancer	3.13e-06	0.000112	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—brain cancer	3.06e-06	0.00011	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO2—brain cancer	3.05e-06	0.000109	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—brain cancer	3.01e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—brain cancer	2.27e-06	8.15e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.4e-06	5.02e-05	CbGpPWpGaD
